Literature DB >> 11874857

Depletion of human NK and CD8 cells prior to in vitro H1N1 flu vaccine stimulation increases the number of gamma interferon-secreting cells compared to the initial undepleted population in an ELISPOT assay.

Christophe Dercamp1, Violette Sanchez, Julie Barrier, Emanuelle Trannoy, Bruno Guy.   

Abstract

In order to study the respective roles of CD4, CD8, and CD56 (NK) cells in gamma interferon (IFN-gamma) production after in vitro stimulation with flu vaccine in a healthy adult human population, we depleted these cellular subtypes before stimulation with antigen (inactivated split vaccine, A/Texas H1N1, or A/Sydney H3N2). We observed that while CD4 cells were required for IFN-gamma secretion in both conditions in vitro, CD56 (NK) cells and, to a lesser extent, CD8 cells had a negative effect on such synthesis upon H1N1 stimulation, as judged by an increased number of spots compared to the initial undepleted population. This regulation of IFN-gamma secretion was associated with an increase in ICAM-1 expression, in particular on T and B cells. This study points out the importance of evaluating in vitro immune responses on a whole-cell population in addition to isolated subtypes if one needs to address potential cellular interactions occurring in vivo in some situations (H1N1 stimulation in the present case). Such cross-regulations occur even in vitro during the antigenic stimulation step.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874857      PMCID: PMC119957          DOI: 10.1128/cdli.9.2.230-235.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  17 in total

Review 1.  Influenza A virus recycling revisited.

Authors:  W R Dowdle
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

Review 2.  Immune regulation: a critical link between NK cells and CTLs.

Authors:  F J Kos; E G Engleman
Journal:  Immunol Today       Date:  1996-04

3.  HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response.

Authors:  K Kuwano; M Scott; J F Young; F A Ennis
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

4.  Regulation of lymphokine response during reinfection by influenza virus. Production of a factor that inhibits lymphokine activity.

Authors:  M A Beck; J F Sheridan
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

5.  Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.

Authors:  S Tamura; K Miyata; K Matsuo; H Asanuma; H Takahashi; K Nakajima; Y Suzuki; C Aizawa; T Kurata
Journal:  J Immunol       Date:  1996-05-15       Impact factor: 5.422

Review 6.  Immunity to influenza in man.

Authors:  R B Couch; J A Kasel
Journal:  Annu Rev Microbiol       Date:  1983       Impact factor: 15.500

7.  Natural killer (NK) cell response after vaccination of volunteers with killed influenza vaccine.

Authors:  J M Schapiro; Y Segev; L Rannon; M Alkan; B Rager-Zisman
Journal:  J Med Virol       Date:  1990-03       Impact factor: 2.327

8.  Independent regulation of lymphocytic choriomeningitis virus-specific T cell memory pools: relative stability of CD4 memory under conditions of CD8 memory T cell loss.

Authors:  S M Varga; L K Selin; R M Welsh
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

9.  Effect of influenza A virus infection on natural and adaptive cellular immunity.

Authors:  D P Skoner; T L Whiteside; J W Wilson; W J Doyle; R B Herberman; P Fireman
Journal:  Clin Immunol Immunopathol       Date:  1996-06

10.  Immunization with purified N1 and N2 influenza virus neuraminidases demonstrates cross-reactivity without antigenic competition.

Authors:  B E Johansson; E D Kilbourne
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

View more
  1 in total

1.  Role of Baicalin in Anti-Influenza Virus A as a Potent Inducer of IFN-Gamma.

Authors:  Ming Chu; Lan Xu; Ming-Bo Zhang; Zheng-Yun Chu; Yue-Dan Wang
Journal:  Biomed Res Int       Date:  2015-12-10       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.